Opportunities and challenges in phenotypic drug discovery: an industry perspective

Nature Reviews Drug Discovery 16, 531 (2017).
doi:10.1038/nrd.2017.111

Authors: John G. Moffat, Fabien Vincent, Jonathan A. Lee, Jörg Eder & Marco Prunotto
Phenotypic drug discovery (PDD) approaches do not rely on knowledge of the identity of a specific drug target or a hypothesis about its role in disease, in contrast to the target-based strategies that have been widely used in the pharmaceutical industry in the past three

Source: Nature Reviews Drug Discovery - July 7, 2017 Category: Drugs & Pharmacology Authors: John G. Moffat Fabien Vincent Jonathan A. Lee J ö rg Eder Marco Prunotto Tags: Perspectives Source Type: research